Bioject Inc. Adds To Its Global Distribution Network

             Bioject Inc. Adds To Its Global Distribution Network

PR Newswire

TIGARD, Ore., April 22, 2014

TIGARD, Ore., April 22, 2014 /PRNewswire/ --Bioject Medical Technologies Inc.
(OTC Pink: BJCT), a leading developer of needle-free injection systems
announced the appointment of Needle Free Solutions, LLC as the company's
exclusive distributor for Pain Management applications in North America. The
agreement calls for the sale of the Biojector®2000 gas-powered device and
accessories for use in the application.

"We are excited to be the exclusive distributor of the Bioject's B2000
Needle-Free Injection System for use with pain management applications in both
clinics and hospitals," said Dr. Michael Duzey, President of Needle Free
Solutions. "We have found that both clinicians and patients have been pleased
with the needle-free injections system. Clinicians are excited and satisfied
with the ease of use of the injection and patients prefer needle-free to the
traditional needle and syringe delivery."

"Needle Free Solutions, Dr. Duzey and his group bring special expertise and
capabilities to this important area," according to Mark Logomasini, Bioject's
President and CEO. "With Bioject's proven technology and Needle Free Solutions
understanding of patient needs, this collaboration will significantly increase
the options available for treatment."

Biojectalso announced the appointment of iHealthNet, LLC as the company's
representative in the European Union. "The partnership with iHealthNet in
South Asia, the Middle East, andAfricahas been very successful," stated Mark
Logomasini, Bioject's President and CEO. "When it came to increasing our
presence inEurope, it was an easy decision to expand our relationship with

Tawfiq Hassan, CEO of iHealthNet commented,"Responding to the increasing cost
of healthcare services and keeping safety and ease of use in mind, Bioject's
needle-free injection therapy devices are the best option iHealthNet can offer
to the European and African markets immediately," and also added "We are very
excited to be able to bring the latest in needle-free syringe devices within
their reach."

Bioject Medical Technologies Inc., based in Tigard, Oregon, USA, is a
developer and manufacturer of needle-free injection therapy systems (NFITS).
NFITS works by forcing medication at high speed through a tiny orifice held
against the skin. This creates a fine stream of high-pressure fluid
penetrating the skin and depositing medication in the tissue beneath. Bioject
is focused on developing mutually beneficial agreements with leading
pharmaceutical, biotechnology, and veterinary companies, as well as research,
global health and government organizations.

Needle Free Solutions is located in Mundelein, Illinois, USA and dedicated to
providing safe and advanced therapies for pain management healthcare providers
and patients.

iHealthNet, LLC. is a US registered company comprised of a talented group of
biotechnology enthusiasts with the common goal of providing advanced and
cost-effective healthcare solutions to patients and medical practitioners on
an individual, collective, and nationwide basis.

Readers and potential investors are cautioned that an investment in the
Bioject's securities involve an EXTREMELY high degree of risk. Such risks
include, without limitation, the risk that the distribution agreement will not
be successful due to the time required in obtaining government clearances and
the risk that the Company may be unable to comply with the extensive
government regulations applicable to the international business. Bioject (OTC
Pink: BJCT) trades on the OTC Pink tier of the OTC market. Investors can find
Real-Time quotes and market information for the Company on

For more information about Bioject, Needle Free Solutions and iHealthNet,
visit, www.needlefreesolutions.comand

SOURCE Bioject Medical Technologies Inc.

Contact: For Further Information Contact: Bioject Medical Technologies Inc.,
Mark Logomasini, President and CEO, 503-692-8001, Christine Farrell, Vice
President of Finance, 503-692-8001 ext. 4132
Press spacebar to pause and continue. Press esc to stop.